Press release

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 9:00 am Pacific Time LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology

articleOrthofix Medical Inc.February 17, 20253/company/orthofix-medical-inc/news/orthofix-participate-canaccord-genuity-2025-musculoskeletal-conference-2025-02-17
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

About this update from Orthofix Medical Inc.

[{"type":"text","content":"\nMonday, March 10, 2025 at 9:00 am Pacific Time\n\n\n LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT.\n\n\nInterested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.com.\n\n\nInternet Posting of Information\n\n\nOrthofix routinely posts information that may be important to investors in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.\n\n\nAbout Orthofix\n\n\nOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit Orthofix.com and follow on LinkedIn.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250217222637/en/\n\nInvestors and Media\nJulie Dewey, IRC\nChief Investor Relations & Communications Officer\[email protected]\n209.613.6945\n\n\nSource: Orthofix Medical Inc.","length":4522,"tagName":"div"}]

More updates from Orthofix Medical Inc.